title: Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways.
authors.forename: David W
authors.initials: DW
authors.lastname: Greening
authors.forename: Sze Ting
authors.initials: ST
authors.lastname: Lee
authors.forename: Hong
authors.initials: H
authors.lastname: Ji
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Simpson
authors.forename: Angela
authors.initials: A
authors.lastname: Rigopoulos
authors.forename: Carmel
authors.initials: C
authors.lastname: Murone
authors.forename: Catherine
authors.initials: C
authors.lastname: Fang
authors.forename: Sylvia
authors.initials: S
authors.lastname: Gong
authors.forename: Graeme
authors.initials: G
authors.lastname: O'Keefe
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Scott